Discover how label-free live cell imaging is transforming the way we study cell behavior, delivering quantitative, real-time insights without dyes or labels. In this seminar co-hosted by Nanolive and the Nanowell Cytometry Platform (MIT Koch Institute) from April 9, explore real-world applications in cancer cell death and immune engineering, featuring research from MIT, Mass General Hospital and Harvard Medical School:
“Engineering Immune Cells to Overcome the Cancer Cell Glycocalyx”
Sangwoo Park, PhD – Instructor, Mass General Hospital & Harvard Medical School
In this talk, strategies to engineer immune cells to overcome the dense cancer cell glycocalyx, a key physical and biochemical barrier to effective anti-tumor responses, are discussed. Learn how glycocalyx-targeted cell engineering can enhance immune synapse formation, tumor recognition, and killing.
“A New Window into Ferroptosis: Label-Free Imaging of Cellular Death”
Ryan Mansell – Graduate Student, Koch Institute for Integrative Cancer Research, MIT
Ferroptosis is an iron-dependent form of cell death driven by lipid peroxidation and membrane damage. This talk highlights the use of Nanolive’s label free imaging technology to identify defining features of this cell death cascade.
Read our latest news
Online walkthrough – Replace fragmented assays: one workflow for cell therapy assessment
Ferroptosis and CAR-T Engineering: Research from MIT
